|
BGI Genomics Co. is a leading provider of genomic and proteomic sequencing services primarily to academic institutions, pharmaceutical companies and healthcare providers. The company also provides genomic solutions for biomarker research and development, screening for some of the trisomies present at birth (trisomy 21, trisomy 18 and trisomy 13) and solutions for neo-antigen identification for immuno-oncology research.
Number of employees : 4 333 people.
|
|
| 2020 | 2021 | Delta | Integrated Solutions for Precision Medical Testing | 5 562.29 | 66.2% | 3 382.12 | 50% | -39.2% |
Reproductive Health Basic Research and Clinical Application | 1 177.90 | 14% | 1 192.49 | 17.6% | +1.24% |
Infection Prevention and Control Basic Research and Clinical Application | 669.57 | 8% | 1 158.41 | 17.1% | +73.01% |
Multi-omics Big Data Service and Synthetic | 625.92 | 7.5% | 641.59 | 9.5% | +2.5% |
Tumor Prevention and Control and Translational Medicine | 351.24 | 4.2% | 379.78 | 5.6% | +8.12% |
Other | 10.31 | 0.1% | 11.75 | 0.2% | +13.96% |
CNY in Million |
|
|
| 2020 | 2021 | Delta | China (Excluding Hong Kong, Macau and Taiwan) | 2 798.39 | 33.3% | 2 884.58 | 42.6% | +3.08% |
Asia (Including Hong Kong, Macau and Taiwan) and Oceania | 3 776.60 | 45% | 2 510.67 | 37.1% | -33.52% |
Europe and Africa | 989.70 | 11.8% | 938.75 | 13.9% | -5.15% |
Americas | 832.55 | 9.9% | 432.13 | 6.4% | -48.1% |
CNY in Million |
|
|
| Vote  | Quantity | Free-Float | Company-owned shares | Total Float |
Stock A |
1 |
419,914,466 |
216,195,351 |
51.5% |
6,000,141 |
1.4% |
51.5% |
|
|
Name | Equities | % | Jian Hua Wang | 153,590,467 |
58.7% | Jun Wang | 34,470,455 |
13.2% | Wanjia Asset Management Co., Ltd. | 15,708,531 |
6.00% | Shenzhen Heyu Gaolin Equity Investment LP | 14,791,666 |
5.65% | Tianjin Liren Enterprise Management Consulting Co. Ltd. | 4,037,106 |
1.54% | BGI Genomics Co. Ltd. ESOP | 4,000,000 |
1.53% | E Fund Management Co., Ltd. | 3,314,087 |
1.27% | Hwabao WP Fund Management Co., Ltd. | 3,276,793 |
1.25% | Qian Xing He | 2,820,936 |
1.08% | BGI Genomics Co., Ltd. | 2,711,024 |
1.04% |
|
|
Name | Equities | % | Valuation |
BGI GENOMICS CO., LTD. (300676) |
2,711,024 |
1.04% |
24,956,603 USD |
LIAONING HE EYE HOSPITAL GROUP CO., LTD. |
1,065,173 |
1.15% |
5,756,536 USD |
|
|
|
- Bloomberg Code : |
|
- Reuters Code : |
300676.SZ |
- Datastream Code : |
|
|
Company contact information |
|
BGI Genomics Co., Ltd. Building NO.7, BGI Park 21 Hongan 3rd Street CN-GD 518083 Shenzhen, Guangdong Phone : +86 755 36307065 Fax : web site : https://www.bgi.com
|
|
|
|
Exclusive: EU antitrust regulators likely to block Illumina, Grail deal - sources |
Sector Bio Diagnostics & Testing
Connections : BGI Genomics Co., Ltd.
|